XRF Scientific Ltd


XRF Scientific Ltd

Health CareMedical Equipment and Services
  • Price (AUD)0.86
  • Today's Change0.035 / 4.24%
  • Shares traded173.17k
  • 1 Year change+57.80%
  • Beta1.0639
Data delayed at least 20 minutes, as of Jan 27 2023 04:54 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • XRF:ASX price moved over +3.03% to 0.85
  • XRF:ASX trading volume exceeds daily average by +18.91%
  • XRF:ASX price rises above 15-day moving average to 0.85 at 10:42 GMT

Key statistics

On Friday, XRF Scientific Ltd (XRF:ASX) closed at 0.86, -3.37% below its 52-week high of 0.89, set on Jan 03, 2023.
52-week range
0.51Jun 14 20220.89Jan 03 2023
Previous close0.825
Average volume100.65k
Shares outstanding136.98m
Free float87.22m
P/E (TTM)19.16
Market cap117.80m AUD
EPS (TTM)0.0449
Annual div (ADY)0.0333
Annual div yield (ADY)2.91%
Div ex-dateSep 29 2022
Div pay-dateOct 14 2022
Data delayed at least 20 minutes, as of Jan 27 2023 04:54 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.